BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23827073)

  • 21. Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients.
    Oh KH; Moon JY; Oh J; Kim SG; Hwang YH; Kim S; Lee JS; Ahn C
    Nephrol Dial Transplant; 2008 Jul; 23(7):2356-64. PubMed ID: 18178604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
    La Milia V; Limardo M; Cavalli A; Crepaldi M; Locatelli F
    Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis.
    Johnson DW; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Badve SV
    Nephrol Dial Transplant; 2010 Jun; 25(6):1973-9. PubMed ID: 20097847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritoneal protein transport during the baseline peritoneal equilibration test is an accurate predictor of the outcome of peritoneal dialysis patients.
    Pérez-Fontán M; Rodríguez-Carmona A; Barreda D; López-Muñiz A; Blanco-Castro N; García-Falcón T
    Nephron Clin Pract; 2010; 116(2):c104-13. PubMed ID: 20502046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport.
    Rodrigues A; Martins M; Santos MJ; Fonseca I; Oliveira JC; Cabrita A; Melo e Castro J; Krediet RT
    Adv Perit Dial; 2004; 20():8-12. PubMed ID: 15384786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term survival and its relationship to membrane transport status in peritoneal dialysis.
    Dasgupta MK; Perry D; Royer R; Fox S
    Adv Perit Dial; 2000; 16():15-8. PubMed ID: 11045253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of serum albumin level in patients receiving continuous ambulatory peritoneal dialysis.
    Sezer S; Ozdemir FN; Akman B; Arat Z; Anaforoglu I; Haberal M
    Adv Perit Dial; 2001; 17():210-4. PubMed ID: 11510278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of correlation between baseline peritoneal membrane status and pre-dialytic characteristics.
    Balafa O; Vlahu C; Sampimon D; Coester AM; Struijk DG; Krediet RT
    Adv Perit Dial; 2010; 26():16-20. PubMed ID: 21348373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
    Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
    Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peritoneal albumin leakage: 2 year prospective cardiovascular event occurrence and patient survival analysis.
    Elsurer R; Afsar B; Sezer S; Ozdemir FN; Haberal M
    Nephrology (Carlton); 2009 Dec; 14(8):712-5. PubMed ID: 20025678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of bioelectrical impedance analysis in monitoring nutrition status and survival of peritoneal dialysis patients.
    Fein PA; Gundumalla G; Jorden A; Matza B; Chattopadhyay J; Avram MM
    Adv Perit Dial; 2002; 18():195-9. PubMed ID: 12402618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal equilibration test with conventional 'low pH/high glucose degradation product' or with biocompatible 'normal pH/low glucose degradation product' dialysates: does it matter?
    Van Overmeire L; Goffin E; Krzesinski JM; Saint-Remy A; Bovy P; Cornet G; Bovy C
    Nephrol Dial Transplant; 2013 Jul; 28(7):1946-51. PubMed ID: 23223220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Faster decline of total fluid removal is an independent risk factor for increased motality in patients on peritoneal dialysis].
    Yang ZK; Dong J; Zuo L
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 43(6):844-8. PubMed ID: 22178832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis.
    Wiggins KJ; McDonald SP; Brown FG; Rosman JB; Johnson DW
    Nephrol Dial Transplant; 2007 Oct; 22(10):3005-12. PubMed ID: 17545674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The personal dialysis capacity test is superior to the peritoneal equilibration test to discriminate inflammation as the cause of fast transport status in peritoneal dialysis patients.
    Van Biesen W; Van der Tol A; Veys N; Dequidt C; Vijt D; Lameire N; Vanholder R
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):269-74. PubMed ID: 17699216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inherent high peritoneal transport and ultrafiltration deficiency: their mid-term clinical relevance.
    Reyes MJ; Bajo MA; Hevía C; Del Peso G; Ros S; de Miguel AG; Cirugeda A; Castro MJ; Sánchez-Tomero JA; Selgas R
    Nephrol Dial Transplant; 2007 Jan; 22(1):218-23. PubMed ID: 17005522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: a 2-year prospective study.
    Szeto CC; Law MC; Wong TY; Leung CB; Li PK
    Am J Kidney Dis; 2001 Feb; 37(2):329-36. PubMed ID: 11157374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between dialysate protein loss and membrane transport status in peritoneal dialysis patients.
    Cooper S; Iliescu EA; Morton AR
    Adv Perit Dial; 2001; 17():244-7. PubMed ID: 11510285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.